Seeing Is Believing
Healthcare - Sector
IOVA is currently covered by 5 analysts with an average price target of $9.27. This is a potential upside of $8.39 (11.82%) from yesterday's end of day stock price of $8.29.
Iovance Biotherapeutics's activity chart (see below) currently has 221 price targets and 200 ratings on display. The stock rating distribution of IOVA is 55.56% BUY and 44.44% HOLD.
Analysts average stock forecasts to be materialized ratio is 35.33% with an average time for these price targets to be met of 137.87 days.
Highest price target for IOVA is $16, Lowest price target is $4, average price target is $9.27.
Most recent stock forecast was given by DAVID DAI from UBS on 20-Aug-2026. First documented stock forecast 04-Aug-2017.
Currently out of the existing stock ratings of IOVA, 5 are a BUY (55.56%), 4 are a HOLD (44.44%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 05-Mar-2026
$7
$-1.29 (-15.56%)
$4
Buy Since 20-May-2019
$16
$11.75 (276.47%)
Hold Since 25-Feb-2026
$5
$0.75 (17.65%)
$5
Buy Since 24-Nov-2025
$11
$7.49 (213.39%)
$10
Buy Since 04-Mar-2020
$10
$5.75 (135.29%)
$9
What is IOVA (Iovance Biotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on IOVA (Iovance Biotherapeutics) with a proven track record?
Which analyst has the most public recommendations on IOVA (Iovance Biotherapeutics)?
Which analyst is the currently most bullish on IOVA (Iovance Biotherapeutics)?
Which analyst is the currently most reserved on IOVA (Iovance Biotherapeutics)?